KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

CareDx (CDNA) Invested Capital (2016 - 2025)

CareDx's Invested Capital history spans 13 years, with the latest figure at $303.1 million for Q4 2025.

  • For Q4 2025, Invested Capital fell 19.91% year-over-year to $303.1 million; the TTM value through Dec 2025 reached $303.1 million, down 19.91%, while the annual FY2025 figure was $303.1 million, 19.91% down from the prior year.
  • Invested Capital for Q4 2025 was $303.1 million at CareDx, down from $311.1 million in the prior quarter.
  • Across five years, Invested Capital topped out at $479.8 million in Q2 2021 and bottomed at $256.2 million in Q1 2024.
  • The 5-year median for Invested Capital is $399.7 million (2023), against an average of $381.6 million.
  • The largest annual shift saw Invested Capital soared 365.11% in 2021 before it plummeted 39.35% in 2023.
  • A 5-year view of Invested Capital shows it stood at $465.9 million in 2021, then decreased by 7.51% to $430.9 million in 2022, then tumbled by 39.35% to $261.3 million in 2023, then skyrocketed by 44.81% to $378.4 million in 2024, then dropped by 19.91% to $303.1 million in 2025.
  • Per Business Quant, the three most recent readings for CDNA's Invested Capital are $303.1 million (Q4 2025), $311.1 million (Q3 2025), and $327.4 million (Q2 2025).